Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma

Overview of attention for article published in BMC Cancer, February 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 84 followers.

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma. https://t.co/cwq0r05g6b

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma BMC Cancer (open access) https://t.co/5ue4dm0vxI

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.